Global Health Q2 FY27: revenue up 33.6% to ₹1,469 Cr, net profit up 38.3% to ₹219 Cr
Results · Finvezto · 3 Nov 2026 · Global Health (MEDANTA)
Results Q2 FY27, ₹ Cr
| Q2 FY27 | ₹ Cr | QoQ | YoY |
|---|---|---|---|
| Revenue | 1,469 | +12.7% | +33.6% |
| Operating profit | 370 | +29.0% | +60.3% |
| Net profit | 219 | +39.4% | +38.3% |
| Operating margin | 25.2% | +3.2 pp | +4.2 pp |
| Net margin | 14.9% | +2.9 pp | +0.5 pp |
Key points
- Global Health reported consolidated revenue from operations of Rs 1,469.0 crore for Q2 FY27, operating EBITDA of Rs 370.1 crore, and net profit of Rs 219.1 crore, up 33.6%, 60.2%, and 38.3% from Q2 FY26. NSE filing
- Growth was driven by bed capacity additions and robust patient volumes, while the board approved developing a 500-bed super-specialty hospital in Ghaziabad with an estimated capex of Rs 997 crore. NSE filing
- Revenue was ₹1,469 Cr, up 33.6% on a year earlier and up 12.7% on the quarter before. Finvezto data
What to watch
- Operating margin over the last 4 quarters (Dec 25, Mar 26, Jun 26, Sep 26): 19.4%, 21.0%, 22.0%, 25.2%.
- Net profit over the last 4 quarters (Dec 25, Mar 26, Jun 26, Sep 26), ₹ Cr: 95, 142, 157, 219.
Links
NSE filing (PDF) · Company page · Results tracker
Anand Ganapathy K | SEBI Registered Research Analyst | INH000016630.